Duschinsky, R., Plenen, E., and Heidelberger , C.: The synthesis of 5-fluoropyrimidines . J. Am. Chem. Soc.79: 4559, 1957.
2.
Young, R.C., Bennett, J.E., Geelhoed, G.W., and Levine, A.S.: Fungemia with compromised host resistance. A study of 70 Cases. Ann. Intern. Med.80: 605, 1974.
3.
Shadomy, S.: Further in vitro studies with 5-fluorocytosine. Infect. Immun.2: 484, 1970.
4.
Vandervelde, A.G., Mauceri, A.A., and Johnson, J.E.: 5-fluorocytosine in the treatment of mycotic infections. Ann. Intern. Med.77: 43, 1972.
5.
Steer, P.L., Marks, M.I., Klite, P.D., and Eickhoff, T.C.: 5-fluorocytosine: An oral antifungal compound. Ann. Intern. Med.76: 15, 1972.
6.
Eilard, T., Alestig, K., and Wahlen, P.: Treatment of disseminated candidiasis with 5-fluorocytosine. J. Infect. Dis.130: 155, 1974.
7.
Tassel, D., and Madoff, M.A.: Treatment of Candida species and cryptococcal meningitis with 5-fluorocytosine . JAMA206: 830, 1968.
8.
Fass, R.J., and Perkins, R.L.: 5-fluorocytosine in treatment of cryptococcal and candida mycosis . Ann. Intern. Med.74: 535, 1971.
9.
Neu, H.C.: A report on a new oral antifungal agent for deep-seated infections . Resident and Staff Phys.58: 68, 1973.
10.
Hoeprich, P.D. , Ingraham, J.L., Kleker , E., and Winship. M. J.: Development of resistance to 5-fluorocytosine in Candida parapsilosis during therapy. J. Infect. Dis.130: 112, 1974.
11.
Medoff, G., Comfort, M., and Kobayashi, G.S.: Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms. Proc. Soc. Exp. Biol. Med.138: 571, 1971 .
12.
Rabinovich, S., Shaw, B.D., Bryant , T., and Donta, S.T.: Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice. J. Infect. Dis.130: 28, 1974.
